VENUS REMEDIES LIMITED (VENUSREM)

NSE: ₹1,555.80
BSE: ₹1,559.15
Stock Performance
Corporate Announcements

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Revenue from Operations 98.63 170.19 131.23 105.86 167.02 172.54 194.04 131.85 192.65 179.95 259.01 178.80
YOY Revenue Growth % -36.34% 36.42% 19.9% -28.73% 69.34% 1.38% 47.86% 24.55% 15.35% 4.29% 33.48% 35.61%
Other Income 2.06 2.93 2.42 1.56 10.71 1.74 6.77 8.00 1.68 2.41 4.64 2.55
Total Income 100.69 173.12 133.65 107.42 177.73 174.28 200.81 139.85 194.33 182.36 263.65 181.35
Total Expenses + 92.48 163.27 124.53 97.34 162.92 154.83 175.98 125.15 168.73 149.55 206.07 148.75
Cost of Materials Consumed 72.23 95.18 87.21 69.59 77.41 97.61 104.21 71.33 106.51 93.86 116.25 83.14
Employee Benefit Expense 13.55 16.25 15.12 16.08 19.45 17.39 19.32 19.26 22.03 19.94 23.62 22.56
Other Expenses 17.30 30.86 20.14 18.18 27.68 26.75 49.83 25.79 33.46 37.04 56.42 35.40
Operating Profit 6.15 6.92 6.70 8.52 4.10 17.71 18.06 6.70 23.92 30.40 52.94 30.05
OPM % 6.2% 4.1% 5.1% 8% 2.5% 10.3% 9.3% 5.1% 12.4% 16.9% 20.4% 16.8%
Profit Before Tax + 8.21 9.85 9.12 10.08 14.81 29.36 24.83 14.70 25.60 32.81 57.58 32.60
Tax Expense 3.87 4.40 0.93 5.63 5.55 5.28 10.04 3.01 6.36 7.89 14.11 7.07
Tax % 47.1% 44.7% 10.2% 55.9% 37.5% 18% 40.4% 20.5% 24.8% 24% 24.5% 21.7%
Profit After Tax 4.34 5.45 8.19 4.45 9.26 24.08 14.79 11.69 19.24 24.92 43.47 25.53
EPS (Basic) 3.25 4.07 6.13 3.33 6.92 18.02 11.07 8.75 14.40 18.64 32.51 19.10

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Revenue from Operations 768.73 639.46 537.66 575.18 514.62 341.46 301.84
YOY Revenue Growth % 20.22% 18.93% -6.52% 11.77% 50.71% 13.13% -
Other Income 11.45 20.78 10.17 8.43 17.76 5.31 4.51
Total Income 780.18 660.24 547.83 583.61 532.39 346.77 306.35
Total Expenses + 649.50 591.09 507.50 538.94 475.12 294.79 325.65
Cost of Materials Consumed 387.95 348.82 317.28 372.78 344.04 168.46 189.76
Employee Benefit Expense 84.85 72.24 51.95 43.75 35.89 46.02 30.26
Other Expenses 152.72 122.44 87.48 86.65 95.18 80.31 55.51
Operating Profit 119.23 48.37 30.16 36.24 39.51 46.67 -23.81
OPM % 15.5% 7.6% 5.6% 6.3% 7.7% 13.7% -7.9%
Profit Before Exceptional 130.68 69.15 40.33 44.67 17.62 0.78 -19.30
Exceptional Items 0.00 9.91 0.00 0.00 23.44 -8.81 -8.96
Profit Before Tax + 130.68 79.06 40.33 44.67 41.06 -8.03 -28.26
Tax Expense 31.37 26.51 11.37 -4.32 -13.21 1.96 -1.15
Tax % 24% 33.5% 28.2% -9.7% -32.2% - -
Profit After Tax 99.31 52.55 28.96 48.99 54.27 -10.00 -27.11
EPS (Basic) 74.29 39.32 24.67 37.12 43.97 -8.10 -21.97

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
ASSETS
Non-Current Assets + 470.25 277.47 290.58 314.25 0.00 0.00 478.57
Property, Plant & Equipment 110.23 110.93 121.90 138.13 0.00 0.00 180.16
Capital Work in Progress 51.36 26.39 26.10 25.23 0.00 0.00 64.76
Non-Current Investments 163.95 0.00 0.14 0.14 0.00 0.00 0.14
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 92.20 0.00 77.78 86.54 0.00 0.00 166.73
Current Assets + 405.81 435.75 318.31 264.41 0.00 0.00 253.59
Inventories 129.37 100.49 113.60 125.63 0.00 0.00 140.94
Trade Receivables 116.39 99.26 84.91 30.41 0.00 0.00 31.39
Cash and Cash Equivalents 23.54 55.41 20.07 42.83 0.00 0.00 0.50
Current Investments 73.80 84.09 20.13 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 689.63 589.50 478.05 449.41 0.00 0.00 340.95
Equity Share Capital 13.37 13.37 13.37 13.37 0.00 0.00 12.34
Other Equity 676.26 576.13 464.68 436.05 0.00 0.00 328.61
Non-Current Liabilities 28.20 18.48 58.17 46.63 0.00 0.00 136.74
Current Liabilities 158.23 105.24 72.67 82.62 0.00 0.00 254.46
Total Liabilities 186.43 123.72 130.84 129.25 0.00 0.00 391.20

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Cash from Operating Activities 151.09 83.10 28.05 40.90 0.00 0.00 0.00
Cash from Investing Activities -181.57 -76.20 -50.81 -16.65 0.00 0.00 0.00
Cash from Financing Activities -1.39 0.00 0.00 -9.13 0.00 0.00 0.00
Net Increase/Decrease in Cash -31.87 6.90 -22.76 15.12 0.00 0.00 0.00